Cited by 168

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways

Park, Jae-Il, Lee, Min-Goo, Cho, Kyucheol, Park, Bum-Joon, Chae, Kwon-Seok, Byun, Do-Sun, Ryu, Byung-Kyu, Park, Yong-Keun, Chi, Sung-Gil·2003·Oncogene

Abstract

Transforming growth factor (TGF)-beta1 acts as a potent growth inhibitor of prostate epithelial cells, and aberrant function of its receptor type I and II correlates with tumor aggressiveness. However, intracellular and serum TGF-beta1 levels are elevated in prostate cancer patients and further increased in patients with metastatic carcinoma, suggesting the oncogenic switch of TGF-beta1 role in prostate tumorigenesis. Recently, we reported the mitogenic conversion of TGF-beta1 effect by oncogenic Ha-Ras in prostate cancer cells. Here, we show that TGF-beta1 activates interleukin (IL)-6, which has been implicated in the malignant progression of prostate cancers, via multiple signaling pathways including Smad2, nuclear factor-kappaB (NF-kappaB), JNK, and Ras. TGF-beta1-induced IL-6 gene expression was strongly inhibited by DN-Smad2 but not by DN-Smad3 while it was further activated by wild-type Smad2 transfection. IL-6 activation by TGF-beta1 was accompanied by nuclear translocation of NF-kappaB, which was blocked by the p38 inhibitors SB202190 and SB203580 or by IkappaBalphaDeltaN transfection, indicating the crucial role for the p38-NF-kappaB signaling in TGF-beta1 induction of IL-6. TGF-beta1 activated c-Jun phosphorylation, and IL-6 induction by TGF-beta1 was severely impeded by DN-c-Jun and DN-JNK or AP-1 inhibitor curcumin, showing that the JNK-c-Jun-AP-1 signaling plays a pivotal role in TGF-beta1 stimulation of IL-6. It was also found that the Ras-Raf-MEK1 cascade is ac…

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1206478

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Entire pathways such as MAPK are no longer hijacked for non-canonical induction of TGF-beta, Smad1, and inflammation but instead engage in productive signaling by their cognate ligands, promoting tissue health, regeneration, and homeostatic production of cytokines and growth factors.

    “entire pathways (MAPK, for example) are no longer hijacked for non-canonical induction of TGF-beta, Smad1, and inflammation [57, 58], but instead engage in productive signaling by their cognate ligands, promoting tissue health, regeneration and homeostatic production of cytokines and growth factors [59–61] (with their own positive feed-backs), as we observe.”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT and Thompson TC . (1999). J. Urol., 161, 182–187. · DOI
  2. Asschert JG, Vellenga E, Ruiters MH and de Vries EG . (1999). Int. J. Cancer, 82, 244–249. · DOI
  3. Atfi A, Buisine M, Mazars A and Gespach C . (1997). J. Biol. Chem., 272, 24731–24734. · DOI
  4. Barrack ER . (1997). Prostate, 31, 61–70. · DOI
  5. Berghe WV, De Bosscher K, Boone E, Plaisance S and Haegeman G . (1999). J. Biol. Chem., 274, 32091–32098. · DOI
  6. Brennan CM and Steitz JA . (2001). Cell. Mol. Life Sci., 58, 266–277. · DOI · Paper page
  7. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY and Ballard DW . (1995). Mol. Cell. Biol., 15, 2809–2818. · DOI
  8. Chen CY, Del Gatto-Konczak F, Wu Z and Karin M . (1998). Science, 280, 1945–1949. · DOI
  9. Chen X, Rubock MJ and Whitman MA . (1996). Nature, 383, 691–696. · DOI
  10. Chung TDK, Yu JJ, Kong TA, Spade MT and Lin JM . (2000). Prostate, 42, 1–7. · DOI
  11. Cohen T, Nahari D, Cerem LW, Neufeld G and Levi B-Z . (1996). J. Biol. Chem., 271, 736–741. · DOI
  12. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM and Glembotski CC . (2000). J. Biol. Chem., 275, 23814–23824. · DOI
  13. Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM and Serve H . (2000). Blood, 95, 2630–2636. · DOI
  14. Datto MB, Yu Y and Wang XF . (1995). J. Biol. Chem., 270, 28623–28628. · DOI
  15. Deeble PD, Murphy DJ, Parsons SJ and Cox ME . (2001). Mol. Cell. Biol., 21, 8471–8482. · DOI
  16. Dixon DA, Tolley ND, King PH, Nabors B, McIntyre TM, Zimmerman GA and Prescott SM . (2001). J. Clin. Invest., 108, 1657–1665. · DOI
  17. Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M and Murphy GP . (1999). Prostate, 41, 127–133. · DOI
  18. Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hildebrand P, Perruchoud AP and Roth M . (1999). J. Biol. Chem., 274, 12933–12938. · DOI
  19. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW and Young LS . (1999). J. Biol. Chem., 274, 16085–16096. · DOI
  20. Eustace D, Han X, Gooding R, Rowbottom A, Riches P and Heyderman E . (1993). Gynecol. Oncol., 50, 15–19. · DOI
  21. Franchimont N, Durant D, Rydziel S and Canalis E . (1999). J. Biol. Chem., 274, 6783–6789. · DOI
  22. Franchimont N, Rydziel S and Canalis E . (2000). Bone, 26, 249–253. · DOI
  23. Giri D, Ozen M and Ittmann M . (2001). Am. J. Pathol., 159, 2159–2165. · DOI
  24. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K and Nishida E . (1999). J. Biol. Chem., 274, 27161–27167. · DOI
  25. Heldin CH, Miyazono K and ten Dijke P . (1997). Nature, 390, 465–471. · DOI
  26. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG and Glass CK . (1997). Proc. Natl. Acad. Sci. USA, 94, 1074–1079. · DOI
  27. Inagaki Y, Truter S and Ramirez F . (1994). J. Biol. Chem., 269, 14828–14834. · DOI
  28. Junn E, Lee KN, Ju HR, Han SH, Im JY, Kang HS, Lee TH, Bae YS, Ha KS, Lee ZW, Rhee SG and Choi I . (2000). J. Immunol., 165, 2190–2197. · DOI
  29. Kishimoto T, Akira S and Taga T . (1992). Science, 258, 593–597. · DOI · Paper page
  30. Kossakowska AE, Edwards D, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA and Janowska-Wieczorek A . (1999). Blood, 94, 2080–2089. · DOI
  31. Krause A, Holtmann H, Eickemeier S, Winzen R, Szamel M, Resch K, Saklatvala J and Kracht M . (1998). J. Biol. Chem., 273, 23681–23689. · DOI
  32. Labbe E, Silvestri C, Hoodless PA, Wrana JL and Attisano L . (1998). Mol. Cell, 2, 109–120. · DOI
  33. Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM and Wang XF . (1999). Proc. Natl. Acad. Sci. USA, 96, 4844–4849. · DOI
  34. Lou W, Ni Z, Dyer K, Tweardy DJ and Gao AC . (2000). Prostate, 42, 239–242. · DOI
  35. Ma W, Cheng S, Campbell C, Wright A and Furneaux H . (1996). J. Biol. Chem., 271, 8144–8151. · DOI · Paper page
  36. Markowitz S, Wang J, Meyeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Wilson JKV . (1995). Science, 268, 1336–1338. · DOI
  37. Massague J . (1990). Annu. Rev. Cell. Biol., 6, 597–641. · DOI
  38. Mazzarelli P, Scuderi F, Mistretta G, Provenzano C and Bartoccioni E . (1998). J. Neuroimmunol., 87, 185–188. · DOI
  39. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T and Kishimoto T . (1989). FEBS Lett., 250, 607–610. · DOI
  40. Ming X-F, Kaiser M and Moroni C . (1998). EMBO J., 17, 6039–6048. · DOI
  41. Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y and Okudaira H . (1998). J. Biol. Chem., 273, 24832–24838. · DOI
  42. Mulder KM and Morris SL . (1992). J. Biol. Chem., 267, 5029–5031. · DOI
  43. Norris JL and Baldwin AS Jr . (1999). J. Biol. Chem., 274, 13841–13846. · DOI
  44. Oft M, Heinz K-H and Beug H . (1998). Curr. Biol., 8, 1243–1252. · DOI
  45. Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann E . (1996). Genes Dev., 10, 2462–2477. · DOI
  46. Okamoto M, Webber MM, Quader S and Oyasu R . (1998). Prostate, 35, 255–262. · DOI
  47. Qiu Y, Ravi L and Kung H-J . (1998a). Nature, 393, 83–85. · DOI
  48. Qiu Y, Robinson D, Pretlow TG and Kung HJ . (1998b). Proc. Natl. Acad. Sci. USA, 95, 3644–3649. · DOI
  49. Ross J . (1995). Microbiol. Rev., 59, 423–450. · DOI · Paper page
  50. Ross J . (1996). Trends Genet., 12, 171–175. · DOI
  51. Sehgal I and Thompson TC . (1999). Mol. Biol. Cell., 10, 407–416. · DOI
  52. Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F and Kurzrock R . (1997). Am. J. Med., 102, 21–28. · DOI
  53. Siegsmund MJ, Yamazaki H and Pastan I . (1994). J. Urol., 151, 1396–1399. · DOI
  54. St-Arnaud R and Quelo I . (1998). Front. Biosci., 3, D838–D848. · DOI
  55. Troppmair J, Hartkamp and Rapp U . (1998). Oncogene, 17, 685–690. · DOI
  56. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT and Thompson TC . (1993). Hum. Pathol., 24, 4–9. · DOI
  57. Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY and Simons JW . (1995). Urology, 45, 542–549. · DOI
  58. Wery-Zennaro S, Zugaza JL, Letourneur M, Bertoglio J and Pierre J . (2000). Oncogene, 19, 1596–1604. · DOI
  59. Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM and Wang XF . (1999). Mol. Cell. Biol., 19, 1821–1830. · DOI
  60. Yakymovych I, Engstrom U, Grimsby S, Heldin CH and Souchelnytski S . (2002). Biochemistry, 41, 11000–11007. · DOI
  61. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT and Wang XF . (1997). Mol. Cell. Biol., 17, 7019–7028. · DOI
  62. Zhao Y and Young SL . (1996). J. Biol. Chem., 271, 2369–2372. · DOI
  63. Zhou S, Zawel L, Lengauer C, Kinzler KW and Vogelstein B . (1998). Mol. Cell, 2, 121–127. · DOI

Cited by

Sorted by citations

Metadata

Authors
Park, J.-I., Lee, M.-G., Cho, K., Park, B.-J., Chae, K.-S., Byun, D.-S., Ryu, B.-K., Park, Y.-K., & Chi, S.-G.
Venue
Oncogene
Published
2003-07-10
Volume
22
Issue
28
Pages
4314-4332
ISSN
  • 0950-9232
  • 1476-5594
Cited by
168
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review